A total of 43,000 samples have been collected from around 2,800 donors. The samples include blood derivatives, DNA, pluripotent mononuclear cells fro1
The Stem Cells for Huntington's Disease (SC4HD) is a new international consortium created to promote advanced therapy medicinal product (ATMP) throug1
Researchers from IDIBAPS and CIBERONC have analysed the interaction between follicular lymphoma and its tumour microenvironment and propose a new pro1
Researchers from the Hospital Clínic-IDIBAPS have developed a calculator to predict the probability of COVID-19 patients with acute respiratory failu1
A new study led by researchers at Hospital Clínic-IDIBAPS and the Pompeu Fabra University provides the largest catalogue to date of postnatal molecul1
A study led by researchers from the Clínic-IDIBAPS and the CIBEREHD and published in the Journal of Hepatology shows that up to 9% of patients with a1
A study by IDIBAPS-CSIC has identified a mechanism that favors the accumulation of the accumulation of defective mitochondria found in diseases such1
In a study published in the Journal of Clinical Oncology, researchers from the Hospital Clínic-IDIBAPS-UB and SOLTI showed the predictive capacity of1
This methodology makes it possible to determine the risk of developing these diseases before symptoms appear in people with REM sleep behavior disord1
An article published in the journal Nature suggests that immunotherapy is effective in patients with HCC of viral origin but does not increase surviv1
